Literature DB >> 25540323

Reply to comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

Yvette I Sheline1, Tim West2, Kevin Yarasheski3, Mateusz S Jasielec4, Jane C Hettinger5, Danielle L Tripoli5, Chengjie Xiong6, Christine Frederiksen7, Monica V Grzelak8, Randall J Bateman5, John C Morris9, Jin-Moo Lee5, John R Cirrito5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25540323      PMCID： PMC4778730          DOI： 10.1126/scitranslmed.3010609

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


× No keyword cloud information.
  5 in total

1.  Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system.

Authors:  Yafei Huang; Rachel Potter; Wendy Sigurdson; Anna Santacruz; Shirley Shih; Yo-El Ju; Tom Kasten; John C Morris; Mark Mintun; Stephen Duntley; Randall J Bateman
Journal:  Arch Neurol       Date:  2011-09-12

2.  Comment on "An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice".

Authors:  Johan Fredrik Emilsson; Ulf Andreasson; Kaj Blennow; Elias Eriksson; Henrik Zetterberg
Journal:  Sci Transl Med       Date:  2014-12-24       Impact factor: 17.956

3.  Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans.

Authors:  John R Cirrito; Brianne M Disabato; Jessica L Restivo; Deborah K Verges; Whitney D Goebel; Anshul Sathyan; Davinder Hayreh; Gina D'Angelo; Tammie Benzinger; Hyejin Yoon; Jungsu Kim; John C Morris; Mark A Mintun; Yvette I Sheline
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

4.  Decreased clearance of CNS beta-amyloid in Alzheimer's disease.

Authors:  Kwasi G Mawuenyega; Wendy Sigurdson; Vitaliy Ovod; Ling Munsell; Tom Kasten; John C Morris; Kevin E Yarasheski; Randall J Bateman
Journal:  Science       Date:  2010-12-09       Impact factor: 47.728

5.  An antidepressant decreases CSF Aβ production in healthy individuals and in transgenic AD mice.

Authors:  Yvette I Sheline; Tim West; Kevin Yarasheski; Robert Swarm; Mateusz S Jasielec; Jonathan R Fisher; Whitney D Ficker; Ping Yan; Chengjie Xiong; Christine Frederiksen; Monica V Grzelak; Robert Chott; Randall J Bateman; John C Morris; Mark A Mintun; Jin-Moo Lee; John R Cirrito
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956
  5 in total
  2 in total

Review 1.  Serotonin, neural markers, and memory.

Authors:  Alfredo Meneses
Journal:  Front Pharmacol       Date:  2015-07-21       Impact factor: 5.810

2.  Serotonin augmentation therapy by escitalopram has minimal effects on amyloid-β levels in early-stage Alzheimer's-like disease in mice.

Authors:  Christian Ulrich von Linstow; Jonas Waider; Manuela Grebing; Athanasios Metaxas; Klaus Peter Lesch; Bente Finsen
Journal:  Alzheimers Res Ther       Date:  2017-09-12       Impact factor: 6.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.